Ovarian cancer - Modern approach to its origin and histogenesis;Rak jajnika - Nowe spojrzenie na pochodzenie i histogenezę

Ginekologia Polska

Volumn 83, Issue 6, 2012, Pages 454-457

  Nowak Markwitz, Ewa ^a   Marek, Spaczyński ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Gene; Hisogenesis; Ovarian cancer; Screening

Indexed keywords

ADENOCARCINOMA; CANCER INVASION; CANCER STAGING; CELL TRANSFORMATION; CLASSIFICATION; CYSTADENOCARCINOMA; EARLY DIAGNOSIS; ENDOMETRIOID CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; REVIEW;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, ENDOMETRIOID; CELL TRANSFORMATION, NEOPLASTIC; CYSTADENOCARCINOMA, SEROUS; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 84866163573     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nowak-Markwitz E, Jankowska A, Spaczyński M. Gonadotropiny a rak jajnika. Ginekol Pol. 2005, 76, 153-162.
2. Fathala M. Incessant ovulation - a factor in ovarian neoplasia? Lancet. 1971, 2, 163.
3. Jäger W, Wildt L, Lang N. Some observation on the effect of a GnRH analogue in ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1989, 32, 137-148.
4. Dubeau L. The cell origin of ovarian epithelial tumors an the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol. 1999, 72, 437-442.
5. Rutgers J, Scully R. Cysts (cystadenomas) and tumors of the rete ovarii. Int J Gynecol Pathol. 1988, 7, 330-342.
6. Luchlan S. The secondary Mullerian system. Obstet Gynecol.1972, 27, 133-146.
7. Narod S, Sun P, Ghardirian P, et al. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 and BRCA2 mutations: a case-control study. Lancet. 2001, 357, 1467-1470.
8. Colgan T, Murphy J, Cole D, et al. Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol. 2001, 25, 1283-1289.
9. Piek J, van Diest P, Zweemer R, et al. Tubal ligation and risk of ovarian cancer. Lancet. 2001, 358, 844.
10. Finch A, Shaw P, Rosen B, et al. Clinical and pathological findings of prophylactic salpinooophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006, 100, 58-64.
11. Medeiros F, Muto M, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinomas in women with familiar ovarian cancer syndrome. Am J Surg Pathol. 2006, 30, 230-236.
12. Cheng W, Liu J, Yoshida H, et al. Lineage infidelity of epithelial ovarian cancer is controlled by HOX genes that specify regional identity in the reproductive tract. Nature Med. 2005, 11, 531-537.
13. Lee Y, Miron A, Drapkin R, [et al.]. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007, 211, 26-35.
14. Kindelberger D, Lee Y, Miron A, [et al.]. Intraepithelial carcinoma of the fimbria and pelvic serous carcimona: evidence for causal relationship. Am J Surg Pathol. 2007, 31, 161-169.
15. Sharma A, Gentry-Maharaj A, Burnell M, et al. Assessing the malignant potential of ovarian inclusion cycts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study. BJOG. 2011, 528, 1471.
16. Cho K, Shih I-M. Ovarian cancer. Ann Rev Pathol Mech Dis. 2009, 4, 287-313.
17. Dinulescu D, Ince T, Quade B, et al. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med. 2005, 11,63-70.
18. Shih I, Kurman R. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004, 164, 1511-1518.
19. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncology. 2009, 10, 327-340.
20. Partridge E, Kreimer A, Greenlee R, et al. Results from four rounds of ovarian cancer screening in a randomized trial. Gynecol Oncol. 2009, 113, 775-782.
21. Swenerton K, Santos J, Gilks C, et al. Histotype predicts the curative potential of radiotherapy. Ann Oncol. 2011, 22, 341-347.